Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지

Purification and refolding of the recombinant subunit B protein of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin

  • Jeon, Yong-Seon (Department of Periodontology, College of Dentistry, Chonbuk National University) ;
  • Seo, Sung-Chan (Department of Periodontology, College of Dentistry, Chonbuk National University) ;
  • Kwon, Jin-Hee (Department of Periodontology, College of Dentistry, Chonbuk National University) ;
  • Ko, Sun-Young (Department of Periodontology, College of Dentistry, Chonbuk National University) ;
  • Kim, Hyung-Seop (Department of Periodontology, College of Dentistry, Chonbuk National University)
  • Published : 2008.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Aggregatibacter actinomycetemcomitans is associated with localized aggressive periodontitis. It produces cytolethal distending toxin (CDT), which induces cell cycle arrest in the G2/M phase. The CDT holotoxin is composed of CdtA, CdtB, and CdtC. CdtB has structural homology to human DNase I and is an active component of the CDT complex acting as a DNase. In particular, the pattern homology seen in the CdtB subunit has been associated with specific DNase I residues involved in enzyme catalysis, DNA binding, and metal ion binding. So, to study the functions and regulation of recombinant CdtB, we made up a quantity of functional recombinant CdtB and tested it in relation to the metal ion effect. Materials and Methods: We constructed the pET28a-cdtB plasmid from A. actinomycetemcomitans Y4 by genomic DNA PCR and expressed it in the BL21 (DE3) Escherichia coli system. We obtained the functional recombinant CdtB by the refolding system using the dialysis method and then analyzed the DNase activity and investigated the metal ion effect from plasmid digestion. Results: The recombinant CdtB subunit was expressed as the inclusion bodies. We were able to obtain functional recombinant CdtB subunit using refolding system. We confirmed that our refolded recombinant CdtB had DNase activity and was influenced by the metal ions $Mg^{2+}$ and $Ca^{2+}$. Conclusion: We suggest that the factors influencing recombinant CdtB may contribute to CDT associated diseases, such as periodontitis, endocarditic, meningitis, and osteomyelitis.

Keywords

References

  1. Baehni P, Tsai CC, McArthur WP, Hammond BF, Taichman NS. Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism. Infect Immun 1979;24:233-243.
  2. Brandes A, Moller-Hartmann W, Giannitsis E, Diederich KW. Focal meningoencephalitis as initial manifestation of Actinomyces actinomycetemcomitans endocarditis. Med Klin (Munich) 1993;88:88-90.
  3. Helgeland K, Nordby O. Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinomyces actinomycetemcomitans. J Periodontal Res 1993;28:161-165. https://doi.org/10.1111/j.1600-0765.1993.tb01064.x
  4. Nakano K, Inaba H, Nomura R et al. Detection and serotype distribution of Aggregatibacter actinomycetemcomitans in cardiovascular specimens from Japanese patients. Oral Microbiol Immunol 2007;22:136-139. https://doi.org/10.1111/j.1399-302X.2007.00332.x
  5. Paturel L, Casalta JP, Habib G, Nezri M, Raoult D. Actinomyces actinomycetemcomitans endocarditis. Clin Microbiol Infect 2004;10:98-118. https://doi.org/10.1111/j.1469-0691.2004.00794.x
  6. Shenker BJ, Vitale LA, Welham DA. Immune suppression induced by Actinomyces actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect Immun 1990;58:3856-3862.
  7. Slots J, Reynolds HS, Genco RJ. Actinomyces actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun 1980;29:1013-1020.
  8. Sugai M, Kawamoto T, Peres SY et al. The cell cycle-specific growth-inhibitory factor produced by Actinomyces actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998;66:5008-5019.
  9. Fives-Taylor P, Meyer D, Mintz K. Characteristics of Actinomyces actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv Dent Res 1995;9:55-62. https://doi.org/10.1177/08959374950090011001
  10. Shenker BJ, Kushner ME, Tsai CC. Inhibition of fibroblast proliferation by Actinomyces actinomycetemcomitans. Infect Immun 1982;38:986-992.
  11. Shenker BJ, McKay T, Datar S et al. Actinomyces actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 1999;162:4773-4780.
  12. Lara-Tejero M, Galan JE. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol 2002;10:147-152. https://doi.org/10.1016/S0966-842X(02)02316-8
  13. Nesic D, Hsu Y, Stebbins CE. Assembly and function of a bacterial genotoxin. Nature 2004;429:429-433. https://doi.org/10.1038/nature02532
  14. Nishikubo S, Ohara M, Ueno Y et al. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 2003;278:50671-50681. https://doi.org/10.1074/jbc.M305062200
  15. Avenaud P, Castroviejo M, Claret S et al. Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Biochem Biophys Res Commun 2004;318:739-745. https://doi.org/10.1016/j.bbrc.2004.04.089
  16. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000;37:952-963. https://doi.org/10.1046/j.1365-2958.2000.02070.x
  17. Love JD, Hewitt RR. The relationship between human serum and human pancreatic DNase I. J Biol Chem 1979;254:12588-12594.
  18. Saiki K, Konishi K, Gomi T, Nishihara T, Yoshikawa M. Reconstitution and purification of cytolethal distending toxin of Actinomyces actinomycetemcomitans. Microbiol Immunol 2001;45:497-506. https://doi.org/10.1111/j.1348-0421.2001.tb02650.x
  19. Middelberg AP. Preparative protein refolding. Trends Biotechnol 2002;20:437-443. https://doi.org/10.1016/S0167-7799(02)02047-4
  20. Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 2005;99: 303-310. https://doi.org/10.1263/jbb.99.303
  21. Shenker BJ, Besack D, McKay T et al. Actinomyces actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J Immunol 2004;172:410-417. https://doi.org/10.4049/jimmunol.172.1.410
  22. Wising C, Svensson LA, Ahmed HJ et al. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Microb Pathog 2002;33: 49-62. https://doi.org/10.1006/mpat.2002.0516
  23. Akifusa S, Poole S, Lewthwaite J, Henderson B, Nair SP. Recombinant Actinomyces actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 2001;69:5925-5930. https://doi.org/10.1128/IAI.69.9.5925-5930.2001
  24. Shenker BJ, Hoffmaster RH, Zekavat A et al. Induction of apoptosis in human T cells by Actinomyces actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J Immunol 2001;167:435-441. https://doi.org/10.4049/jimmunol.167.1.435
  25. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994;62:244-251.
  26. Evans SJ, Shipstone EJ, Maughan WN, Connolly BA. Site-directed mutagenesis of phosphate-contacting amino acids of bovine pancreatic deoxyribonuclease I. Biochemistry 1999;38:3902-3909. https://doi.org/10.1021/bi9824893
  27. Suck D. DNA recognition by DNase I. J Mol Recognit 1994;7:65-70. https://doi.org/10.1002/jmr.300070203